Related Experiment Videos
Minocycline-induced pigmentation resolves after treatment with the Q-switched ruby laser
1Department of Dermatology, General Infirmary at Leeds, U.K.
The British Journal of Dermatology
|August 1, 1996
Summary
Minocycline-induced skin pigmentation in four patients resolved completely after treatment with the Q-switched ruby laser, with no reported adverse effects.
Area of Science:
- Dermatology
- Laser Medicine
- Pharmacology
Background:
- Minocycline, an antibiotic, can cause cutaneous pigmentation as a side effect.
- This pigmentation, often blue-gray, can be cosmetically concerning for patients.
- Previous treatment options for drug-induced pigmentation have had limited success.
Observation:
- Four patients presented with minocycline-induced cutaneous pigmentation.
- These patients were treated using a Q-switched ruby laser.
- The laser treatment was applied directly to the pigmented skin areas.
Findings:
- Complete resolution of minocycline-induced cutaneous pigmentation was observed in all four treated patients.
- The Q-switched ruby laser treatment was effective in clearing the skin discoloration.
- No adverse effects, such as scarring or persistent inflammation, were reported post-treatment.
Implications:
- The Q-switched ruby laser presents a safe and effective therapeutic option for minocycline-induced cutaneous pigmentation.
- This finding offers a new treatment avenue for patients experiencing this specific drug side effect.
- Further research could explore long-term efficacy and optimal laser parameters for similar pigmentary conditions.